This is the authors' abstract. We don't add key points for this paper.
In Fort Portal, Uganda, artemisinin resistance-associated mutations in Plasmodium falciparum Kelch13 ( n = 126) were present in 4.8% (675V, 561H, and 441L). A mutation of unknown relevance, 490T, occurred in 9.5%. PfMDR1 variants suggested increased lumefantrine tolerance (N86, 100%). Mutation 500N was absent, and 199S occurred in 12.8%. The latter is of unknown relevance. These data indicate an incipient emergence of artemisinin resistance in a crucial location between Rwandan and Ugandan resistance hotspots and hardly affected DR Congo.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Loon et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: